Atlas Trials

A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

Clinical trial NCT00880763 · COMPLETED

Trial details

NCT number
NCT00880763
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2009-04-20
Primary completion
2010-06-03
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.